Observational, Non-interventional Biomarker and Endotyping Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPrenosis, Inc.
About this trial
The goal of this observational study is to establish a centralized ARDS biorepository of longitudinal biospecimens and harmonized clinical data, develop unsupervised, therapy-agnostic endotyping algorithms, and develop unsupervised, therapy-specific treatment-prediction algorithms over a 24 month period.
Eligibility criteria
Qualifiers
Age ≥18 years
ARDS Diagnosis (New Global Definition of ARDS)
Timing: Acute onset within 7 days
Radiology: Bilateral pulmonary opacities
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Prenosis, Inc.
Lead sponsor
Biomedical Advanced Research and Development Authority
Collaborator
Source ClinicalTrials.gov